Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kathera Bioscience
AddedFeb 18, 2024
UpdatedJun 18, 2026
Kathera Bioscience

Kathera Bioscience

Angel

Kathera Bioscience: Innovating broad-spectrum drugs to combat global fungal infections.

HQ
Union, NJ, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Kathera Bioscience was founded with the mission to combat the rising global threat of fungal infections through innovative drug development. The company focuses on creating novel, broad-spectrum antifungal therapies that address the limitations of current treatment options. Their core vision is to significantly reduce the global burden of life-threatening fungal diseases by providing more effective and accessible treatment solutions.

Notable figures affiliated with Kathera Bioscience include leading experts in mycology and pharmaceutical development. The company has garnered attention and support from prominent investors in the biotech sector. Key achievements include the development of promising drug candidates that have shown efficacy in preclinical trials. Kathera Bioscience's impact lies in its potential to revolutionize the treatment landscape for fungal infections, offering hope to millions affected globally.

Kathera Bioscience - Similar Companies

Kainomyx logo

Kainomyx

kainomyx.com

Curie.Bio logo

Curie.Bio

curie.bio

Mycologics logo

Mycologics

mycologics.net

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Zymeron logo

Zymeron

zymeron.com

Kinnear Pharmaceuticals logo

Kinnear Pharmaceuticals

kinnearpharma.com

Petri Bio logo

Petri Bio

petribio.com

KBP Biosciences logo

KBP Biosciences

kbpbiosciences.com

Spectrum Antimicrobials logo

Spectrum Antimicrobials

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

MiniVax logo

MiniVax

MycoMed Technologies logo

MycoMed Technologies

Nano Cures logo

Nano Cures

nanocures.com

Know Bio logo

Know Bio

knowbiollc.com

Actio Biosciences logo

Actio Biosciences

actiobio.com

Kathera Bioscience - Quick Facts

Who are Kathera Bioscience's competitors?

Companies similar to Kathera Bioscience include Kainomyx, Curie.Bio, Mycologics and Kymera Therapeutics.

When was Kathera Bioscience founded?

Kathera Bioscience was founded in 2020.

Where is Kathera Bioscience's headquarters located?

Kathera Bioscience's headquarters is located in Union, NJ, US.

When was Kathera Bioscience's last funding round?

Kathera Bioscience's most recent funding round was for $150k (USD) in August 2022.

How much has Kathera Bioscience raised to-date?

As of Aug 2, 2022, Kathera Bioscience has raised a total of $150k (USD).

How many employees does Kathera Bioscience have?

Kathera Bioscience has 3 employees as of Feb 4, 2024.

Kathera Bioscience - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research